Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
20240722_PR_Biophytis_Contracts_in_Asia_EN
By
admin
July 22, 2024
20240722_CP_Biophytis_Asie_Contrats_en_Asie_FR
By
admin
July 22, 2024
2024-07-11_PR_OBA_IND_Approval_EN
By
admin
July 11, 2024
2024-07-11_CP_Autorisation_IND_OBA_FR
By
admin
July 11, 2024
2024-07-01_PR_WCID_2024
By
admin
July 1, 2024
2024-07-01_CP_WCID_2024
By
admin
July 1, 2024
2024_06_25_PR_AGM_results
By
admin
June 25, 2024
2024_06_25_CP_CR_AGM
By
admin
June 25, 2024
2024-06-20_PR_Blanver_Partnership_EN
By
admin
June 20, 2024
2024-06-20_CP_Accord_Blanver_FR
By
admin
June 20, 2024
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
…
26
27
28
29
30
…
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
